mesembrenone has been researched along with apremilast in 1 studies
Studies (mesembrenone) | Trials (mesembrenone) | Recent Studies (post-2010) (mesembrenone) | Studies (apremilast) | Trials (apremilast) | Recent Studies (post-2010) (apremilast) |
---|---|---|---|---|---|
7 | 0 | 7 | 619 | 96 | 586 |
Protein | Taxonomy | mesembrenone (IC50) | apremilast (IC50) |
---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 0.086 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 0.059 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 0.086 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.1235 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
He, J; Ke, H; Peng, T; Qi, B; Shi, J | 1 |
1 review(s) available for mesembrenone and apremilast
Article | Year |
---|---|
Advances in the Development of Phosphodiesterase-4 Inhibitors.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Development; Drug Discovery; Humans; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Conformation; Quinolones; Vomiting | 2020 |